DŁUG Zmiana Data
AstraZeneca USD 32.24B 1.68B 2026-06
Genmab DKK 5.35B 5.2B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GRIFOLS EUR 8.52B 1.15B 2026-06
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Qiagen NV USD 1.65B 165.82M 2026-03
UCB EUR 3.03B 12M 2024-12